Article contents
Characterization of resistance to newer antimicrobials among carbapenem-resistant Klebsiella pneumoniae in the post–acute-care setting
Published online by Cambridge University Press: 28 July 2022
Abstract
We assessed susceptibility patterns to newer antimicrobial agents among clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from patients in long-term acute-care hospitals (LTACHs) from 2014 to 2015. Meropenem-vaborbactam and imipenem-relebactam nonsusceptibility were observed among 9.9% and 9.1% of isolates, respectively. Nonsusceptibility to ceftazidime-avibactam (1.1%) and plazomicin (0.8%) were uncommon.
- Type
- Concise Communication
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
References
- 1
- Cited by